Abits
ABTS
FRMO CORP
FRMO
Mawson Infrastructure
MIGI
Ebang International
EBON
BIT Mining
BTCM
US Stock MarketDetailed Quotes
NGNE Neurogene
- 17.050
- -0.230-1.33%
Close Mar 10 16:00 ET
- 17.050
- 0.0000.00%
Post 16:00 ET
253.27MMarket Cap-6.02P/E (TTM)
17.400High16.650Low127.28KVolume17.020Open17.280Pre Close2.16MTurnover2.37%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.84P/B91.73MFloat Cap14.42052wk Low--Dividend TTM5.38MShs Float1115.000Historical High--Div YieldTTM4.34%Amplitude7.500Historical Low16.945Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet